Skip to content

LENSAR, Inc. LNSR EPS (Basic)

EPS (Basic) at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$2.17-52.5%
Staar Surgical logo
Staar SurgicalSTAA
$0.10+109%
Bausch + Lomb logo
Bausch + LombBLCO
-$0.20+66.7%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$0.32-45.5%
Schering-Plough logo
Schering-PloughSGP
-$0.69+82.6%
IAR
Integra LifeSciencesIART
-$0.06+81.8%

Other financials

Income statement

See full
Revenue$13.4M-5.2%
Gross profit$6.4M-10.4%
Operating income$2.2M+139%
Net income$36.3M+233%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$12.5M-36.1%
Total debt$7.6M+206%
Total equity$10.8M+149%
Total assets$66.2M-9.2%

Cash flow

See full
Operating cash flow-$4.3M+38.4%
CapEx$77.0K-31.9%
Free cash flow-

Valuation

See full
Market cap$70.13M-53.1%
Enterprise value$65.21M-54.9%
P/E2.4×
P/S1.2×-1.3×

Profitability

See full
Gross margin45.7%-2.1pp
Operating margin-28.7%+7.3pp
Net margin50.9%+30.7pp
FCF margin-26.6%

Returns & leverage

See full
Return on equity-164%-235pp
Debt / equity0.7×
Current ratio2.4×+0.6×

Where this comes from

Reported directly by LENSAR, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The official record: LENSAR, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about LENSAR, Inc.'s eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LENSAR, Inc.'s EPS (basic)?
LENSAR, Inc. (LNSR) reported EPS (basic) of $1.56 in Q1 2026.
How has LENSAR, Inc.'s EPS (basic) changed year-over-year?
LENSAR, Inc.'s EPS (basic) increased by 167.2% year-over-year, from -$2.32 to $1.56.
What is the long-term trend for LENSAR, Inc.'s EPS (basic)?
Over 4 years (2021 to 2025), LENSAR, Inc.'s EPS (basic) has grown at a 8.5% compound annual growth rate (CAGR), from -$2.09 to -$2.90.
What does EPS (basic) mean?
Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.